GSTM1 and hemolysis: The NVA-IT nanoparticles did not alter blood parameters including RBCs, Hb, and PCV; thus, the metabolites did not promote anemia, hemorrhage, or hemolysis in the rats and the balance between the rate of formation and death of blood cells was unaffected.